Seoul Pharma signs US$28m contract with Sandoz AG

10:06
golden horse caption
09:41
Japan voices regret over S. Korea's non-attendance of Sado memorial
16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap
16:01
Over 80,000 malicious calls made to Seoul call center since 2020
12:52
Trump picks ex-N. Korea policy official as his principal deputy national security adviser

Seoul Pharma signs US$28m contract with Sandoz AG

July 11, 2016 - 13:53 By 황유미

[DISCLOSURE] Seoul Pharma (018680) has signed a US$28 million contract with Sandoz AG, an affiliate of Norvartis Group, the company announced on July 11. The 5-year contract is for supplying goods and exclusive licensing patents.

황유미